New Key Statistics Module, Z-Score and F-Score
NAS:KPTI Key Ratios
| Market Cap $ M | 108.49 |
| Enterprise Value $ M | 151.99 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 0.74 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 145.00 |
| EPS (TTM) $ | -1.18 |
| Beneish M-Score | -0.86 |
| 10-y EBITDA Growth Rate % | 11.20 |
| 5-y EBITDA Growth Rate % | 19.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.40 |
| EV-to-EBITDA | -2.41 |
| PEG | -- |
| Shares Outstanding M | 124.68 |
| Net Margin (%) | -61.73 |
| Operating Margin % | -89.89 |
| Pre-tax Margin (%) | -61.53 |
| Quick Ratio | 3.56 |
| Current Ratio | 3.62 |
| ROA % (ttm) | -36.65 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -894.35 |
| Dividend Yield % | -- |
| Altman Z-Score | -9.07 |
KPTI Number of Guru Trades
KPTI Volume of Guru Trades
Gurus Latest Trades with NAS:KPTI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:KPTI is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Karyopharm Therapeutics Inc Insider Transactions
No Available Data
News about NAS:KPTI
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers